ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1254

Eliciting the Research Priorities of Parents and Children with Juvenile Myositis

Colleen K. Correll1, Mitali Dave2, Anne Paul3, Vincent Del Gaizo4 and Esi Morgan5, 1Pediatrics, University of Minnesota, Minneapolis, MN, 2Cure JM Foundation, Encintas, CA, 3Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Parent Partner, Whitehouse Station, NJ, 5Cincinnati Children's Hospital, Cincinnati, OH

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Juvenile myositis and patient engagement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The Patient-Centered Outcomes Research Institute (PCORI) aims to improve the quality and relevance of research by conducting research that is of highest priority to patients and to engage patients at all phases of research. As a project of the PCORI-supported Patient Powered Research Network, PARTNERS (Patients, Advocates and Rheumatology Teams Network for Research and Service), we surveyed parents of children with juvenile myositis (JM) to identify what research questions are most important to them.

Methods: This research prioritization exercise was conducted through web-based surveys, a focus group, and a Delphi process. In November, 2016 a survey link, comprised of 3 open-ended questions to assess what concerns patients/families found most important, was emailed to members of the Cure JM Foundation listserv and posted on Cure JM social media sites. Parents, patients ≥13 years old and family/friends were included. Common themes on research areas of interest were identified from the survey and further characterized through a focus group consisting of parents of children with JM at the annual Cure JM conference in February, 2017. A final survey was created based upon these themes and emailed to the Cure JM listserv and posted to its social media sites in April, 2017. Survey respondents were asked to rank the themes most important to them. Responses were weighted and the 6 most important themes were identified.

Results: There were 138 respondents to the initial survey (77% parents, 11% patients, 12% family/friends). Response rate could not be calculated because the number of potential respondents from social media sites is unknown. From this survey, 23 concerns were identified. The 3 most common concerns were long-term effects of medications, long-term effects of juvenile myositis, and triggers for disease flare. The 23 concerns were further characterized into 20 research priorities during a 9-member focus group. The final ranking survey asked respondents to rank the 7 most important priorities from the 20 themes. There were 365 survey respondents (75% parents, 15% patients, 10% family/friends). The following were ranked in order as the most important research priorities: a cure, new treatments with less side effects, triggers for disease flare, treatment side effects (such as steroids), standards to measure disease activity/remission, genetic/environmental causes of the disease. These research priorities were formally presented at the Global Conference on Myositis and the Childhood Arthritis and Rheumatology Research Alliance annual meetings to help frame the juvenile myositis research agenda.

Conclusion: Patient centered research prioritization is increasingly recognized as a valuable tool in conducting high-quality research, yet there is a lack of publication describing patient/family preferences, especially in pediatrics. Here, we demonstrate a successful program from which we assessed patient/family research priorities in order to inform a joint research agenda process for the juvenile myositis research community.


Disclosure: C. K. Correll, None; M. Dave, None; A. Paul, None; V. Del Gaizo, Sobi, 5; E. Morgan, None.

To cite this abstract in AMA style:

Correll CK, Dave M, Paul A, Del Gaizo V, Morgan E. Eliciting the Research Priorities of Parents and Children with Juvenile Myositis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/eliciting-the-research-priorities-of-parents-and-children-with-juvenile-myositis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/eliciting-the-research-priorities-of-parents-and-children-with-juvenile-myositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology